These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
118 related items for PubMed ID: 9858910
1. Production and characterisation of a recombinant single-chain anti ErbB2-clavin immunotoxin. D'Alatri L, Di Massimo AM, Anastasi AM, Pacilli A, Novelli S, Saccinto MP, De Santis R, Mele A, Parente D. Anticancer Res; 1998; 18(5A):3369-73. PubMed ID: 9858910 [Abstract] [Full Text] [Related]
2. Role of cross-linking agents in determining the biochemical and pharmacokinetic properties of Mgr6-clavin immunotoxins. Dosio F, Arpicco S, Adobati E, Canevari S, Brusa P, De Santis R, Parente D, Pignanelli P, Negri DR, Colnaghi MI, Cattel L. Bioconjug Chem; 1998; 9(3):372-81. PubMed ID: 9576812 [Abstract] [Full Text] [Related]
3. Stabilization of a recombinant Fv fragment by base-loop interconnection and V(H)-V(L) permutation. Brinkmann U, Di Carlo A, Vasmatzis G, Kurochkina N, Beers R, Lee B, Pastan I. J Mol Biol; 1997 Apr 25; 268(1):107-17. PubMed ID: 9149145 [Abstract] [Full Text] [Related]
4. Expression, purification, and refolding of a novel immunotoxin containing humanized single-chain fragment variable antibody against CTLA4 and the N-terminal fragment of human perforin. Wan L, Zeng L, Chen L, Huang Q, Li S, Lu Y, Li Y, Cheng J, Lu X. Protein Expr Purif; 2006 Aug 25; 48(2):307-13. PubMed ID: 16584889 [Abstract] [Full Text] [Related]
5. Clavin, a type-1 ribosome-inactivating protein from Aspergillus clavatus IFO 8605. cDNA isolation, heterologous expression, biochemical and biological characterization of the recombinant protein. Parente D, Raucci G, Celano B, Pacilli A, Zanoni L, Canevari S, Adobati E, Colnaghi MI, Dosio F, Arpicco S, Cattel L, Mele A, De Santis R. Eur J Biochem; 1996 Jul 15; 239(2):272-80. PubMed ID: 8706730 [Abstract] [Full Text] [Related]
6. One-step on-column purification and refolding of a single-chain variable fragment (scFv) antibody against tumour necrosis factor alpha. Liu M, Wang X, Yin C, Zhang Z, Lin Q, Zhen Y, Huang H. Biotechnol Appl Biochem; 2006 Mar 15; 43(Pt 3):137-45. PubMed ID: 16293104 [Abstract] [Full Text] [Related]
7. [Expression and Characterization of Single-chain Fv-Fc Fusion Protein against Human P185(erbB2)]. Xie ZG, Guo N, Shi M, Feng JN, Yu M, Sun YX, Shen BF. Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai); 2003 Apr 15; 35(4):371-4. PubMed ID: 12673393 [Abstract] [Full Text] [Related]
8. Gene cloning, bacterial expression, in vitro refolding, and characterization of a single-chain Fv antibody against PreS1(21-47) fragment of HBsAg. Yang X, Hu W, Li F, Xia H, Zhang Z. Protein Expr Purif; 2005 Jun 15; 41(2):341-8. PubMed ID: 15866720 [Abstract] [Full Text] [Related]
9. Expression, purification, and in vitro refolding of a humanized single-chain Fv antibody against human CTLA4 (CD152). Chen LH, Huang Q, Wan L, Zeng LY, Li SF, Li YP, Lu XF, Cheng JQ. Protein Expr Purif; 2006 Apr 15; 46(2):495-502. PubMed ID: 16243538 [Abstract] [Full Text] [Related]
10. Gene expression and function study of fusion immunotoxin anti-Her-2-scFv-SEC2 in Escherichia coli. Ming-Kai X, Cheng-Gang Z. Appl Microbiol Biotechnol; 2006 Mar 15; 70(1):78-84. PubMed ID: 16080007 [Abstract] [Full Text] [Related]
17. Expression and characterization of bryodin 1 and a bryodin 1-based single-chain immunotoxin from tobacco cell culture. Francisco JA, Gawlak SL, Miller M, Bathe J, Russell D, Chace D, Mixan B, Zhao L, Fell HP, Siegall CB. Bioconjug Chem; 1997 Mar 15; 8(5):708-13. PubMed ID: 9327135 [Abstract] [Full Text] [Related]
18. Comparison of recombinant immunotoxins against LeY antigen expressing tumor cells: influence of affinity, size, and stability. Bera TK, Pastan I. Bioconjug Chem; 1998 Mar 15; 9(6):736-43. PubMed ID: 9815167 [Abstract] [Full Text] [Related]